FeLV Ag FIV TOXO Ab

FeLV Ag FIV TOXO Ab

FeLV Ag FIV TOXO Ab

Product catalog summary
Intended Use: The Feline Leukemia Virus Antigen/Immunodeficiency Virus/Toxoplasma Antibody Combo Rapid Test is a lateral flow immunoassay designed for the simultaneous qualitative detection of specific antigens from Feline Leukemia Virus (FeLV) and specific antibodies from Feline Immunodeficiency Virus (FIV) and Toxoplasma (TOXO) in feline serum, plasma, or whole blood samples.
Reagents and Materials Provided: The kit includes test devices, capillary droppers, buffer, and a package insert.
Materials Required but Not Provided: A timer is needed for the test procedure.
Storage and Stability: The test device should be stored at room temperature (4-30°C) away from light and should not be frozen. It must be used before the expiration date on the package.
Warnings, Precautions, and Safety Information: All samples are potentially infectious, requiring operators to wear protective gloves and wash hands thoroughly. Decontaminate and dispose of all samples and used kits according to regulations.
Test Procedure: Check the kit contents before use. The test should be conducted at room temperature (15–30°C). Results should be read at 5-10 minutes, and are invalid after 15 minutes.
Interpretation of Test Results: A positive result shows both C and T lines, a negative result shows only a clear C line, and an invalid result shows no colored line in the C region.
Specimen Collection, Handling, and Transport: Whole blood, serum, or plasma can be used. Samples should be stored at 2~8°C and frozen at -20°C or below for longer storage. Avoid repeated freezing and thawing.
Performance Characteristics: The diagnostic sensitivity and specificity for FeLV Ag, FIV Ab, and TOXO Ab are high, with total agreement percentages above 96% for each.
Limitations: The test is highly accurate but may produce false results. A definitive diagnosis should not be based solely on this test but should be confirmed by a veterinarian after evaluating all clinical and laboratory findings.
Manufacturer Information: Hangzhou Antigenne Technology Co., Ltd, located in Hangzhou, Zhejiang, China.
See more

Catalog excerpts

FeLV Ag FIV TOXO Ab-1

Feline Leukemia Virus Antigen/ Immunodeficiency Virus/Toxoplasma Antibody Combo Rapid Test(FeLV Ag/FIV/TOXO Ab) Feline Leukemia Virus Antigen/ Immunodeficiency Virus/ Toxoplasma Antibody Combo Rapid Test is a lateral flow immunoassay intended for the simultaneous qualitative detection of specific antigen from Feline Leukemia Virus (FeLV) and specific antibody from Feline Immunodeficiency Virus (FIV)/ Toxoplasma (TOXO) in feline serum, plasma or whole blood samples. The test is useful for simultaneous determination of FeLV Ag/FIV/TOXO Ab infection. Reagent and Materials Provided • Test devices • Capillary droppers • Buffer • Package insert Materials Required but not Provided The test device is sealed and should be stored away from light at a room temperature (4-30oC). Do not freeze. The test device should be used before the expiration date marked on the package label. Warnings, Precautions and Safety Information 1. The test device is used for feline only. 2. The results may be influenced by humidity and temperature. 3. Make sure that the foil pouch containing the test is not damaged before open. Perform the test immediately when the pouch package is opened. 4. Do not reuse the test components. 5. Do not use after the expiry date. 6. Do not mix product components in different lot numbers. 7. As all samples are potentially infectious. Operators should wear protective gloves while handling samples and wash hands thoroughly afterwards. 8. Decontaminate and dispose of all samples, used kits and potentially contaminated materials safely in accordance with national and local regulations. Specimen Collection, Handling, and Transport I.Whole blood, serum or plasma should be used with this test. Whole blood: Collect the whole blood. If whole blood samples are not immediately tested, they should be refrigerated at 2~8°C and used within 24 hours. Serum: Collect the whole blood into the collection tube (NOT containing anticoagulants such as heparin, EDTA and sodium citrate), and then stand or centrifuge whole blood to get serum. Plasma: Collect the whole blood into the collection tube (containing anticoagulants such as heparin, EDTA and sodium citrate) and then stand or centrifuge whole blood to get plasma. 2.Samples should be stored at 2~8°C. Please freeze the samples at -20°C or below for longer storage and avoid repeated freezing and thawing. 3.Samples containing precipitate may yield inconsistent test results. They must be clarified prior to assaying. 4.Hemolyzed or contaminated samples may lead to erroneous results. STEP 1 CHECK THE KIT CONTENTS BEFORE USE Check the product contents and make sure the test operation is under the room temperature (15—30C) before testing. STEP 2 TEST PROCEDURE Take the test device out of the aluminum foil bag, and place it on a clean, flat table. Use a capillary dropper to draw some whole blood/serum/plasma specimens and add one drop (about 10 pL) to each specimen well (S) of the test device. Then, add two drops (about 60 pL) of buffer into each specimen well (S) of the test device. STEP 3 INTERPRETATION OF TEST RESULT Read the result at 5-10 minutes. The result is invalid after 15 minutes. Positive (+): The presence of both C line and T line, regardless of T line being strong or faint. Negative (-): Only clear C line appears. Invalid: No colored line appears in C region, regardless of T line’s appearance. Although the Feline Leukemia Virus Antigen/ Immunodeficiency Virus/ Toxoplasma Antibody Combo Rapid Test is very accurate in simultaneously detecting Feline Leukemia Virus Antigen, Feline Immunodeficiency Virus and Toxoplasma Antibody, a low incidence of false results may be occurred. Other clinically or laboratory tests might be required if questionable results are obtained. As other diagnostic tests, a definitive clinical diagnosis should not be based on the result of a single test, but should be diagnosed by the veterinarian after all clinical and laboratory findings have been evaluated. Performance Characteristics Diagnostic Sensitivity of FeLV Ag: 176/180=97.78%(95%CI* (94.23%-99.33%)) Diagnostic Specificity of FeLV Ag: 165/170=97.06%(95%CI* (93.11%-98.93%)) Total Agreement of FeLV Ag: 341/350=97.43%(95%CI* (95.11%-98.72%))

 Open the catalog to page 1
FeLV Ag FIV TOXO Ab-2

ELISA Method Diagnostic Sensitivity of TOXO Ab: 115/120=95.83%(95%CI* (90.37%-98.46%)) Diagnostic Specificity of TOXO Ab:175/180=97.22%(95%CI* (93.48%-98.99%)) Total Agreement of TOXO Ab:290/300=96.67%(95%CI* (93.89%-98.26%)) batch code contains sufficient for tests in vitro diagnotic medical device temperature limitation Hangzhou Antigenne Technology Co., Ltd Address:Block A, Building 3, No. 8, Xiyuan 9th Road, Xihu District, Hangzhou

 Open the catalog to page 2

All Hangzhou Antigenne Technology Co. Ltd catalogs and technical brochures

  1. BVDV Ag

    1  Page

  2. BVDV Ag

    1  Page

  3. BRU Ab

    1  Page

  4. FPV GIA Ag

    1  Page

  5. CDV CPV Ag

    1  Page

  6. CDV CPIV Ag

    1  Page

  7. CDV CAV Ag

    1  Page

  8. FPV FCoV Ag

    1  Page

  9. ICH Ab

    1  Page

  10. HP Ag

    1  Page

  11. GIA Ag

    1  Page

  12. FPL

    1  Page

  13. FHV Ab

    1  Page

  14. FCV Ab

    1  Page

  15. FCoV Ab

    1  Page

  16. F.IgE

    1  Page

  17. F-BT A+B

    1  Page

  18. CRV Ag

    1  Page

  19. CAV Ag

    1  Page

  20. C.IgE

    1  Page

  21. C.FOB

    1  Page

  22. BC Ab

    1  Page

  23. FIPV Ag

    1  Page

  24. FeLV Ag

    1  Page

  25. FCoV Ag

    1  Page

  26. F.GIA Ag

    1  Page

  27. RAB Ag

    1  Page

  28. CPV Ab

    1  Page

  29. CIV Ag

    1  Page

  30. CAV-II Ag

    1  Page

  31. CAV-I Ag

    1  Page

  32. SE Ag

    1  Page

  33. BRU Ab

    1  Page

  34. FPV/FCoV Ag

    1  Page

  35. ITGen catalog

    28  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.